Many people drink matcha daily. What this article can report is not whether that suits any particular person, but what the intake guidance says and what the measurements show. One to two servings a day is the amount with direct trial evidence behind it, and three quantities rise with every serving added: caffeine, catechins, and lead.
What the Evidence Actually Covers
The direct human record for drinking matcha every day is small. A randomised trial published in 2024 gave 99 adults aged 60-85 a 2g dose daily for 12 months and reported “no cases of a causal relationship between harmful events and matcha consumption.” A second 2024 trial gave 46 adults 2.7g a day for four weeks. That is 145 participants, with 12 months as the longest exposure studied.
A 2022 critical review of matcha in humans located five randomised trials in total, 23-54 participants each, from a single acute dose to 12 weeks, and concluded that “the evidence … is still limited, and conclusions cannot be drawn.”
The long-term evidence people usually have in mind is about a different drink. A 2024 meta-analysis pooled 38 prospective cohort datasets covering 1,956,549 participants and found, for highest versus lowest tea consumption, all-cause mortality 0.90 (95% CI 0.86-0.95), cardiovascular 0.86 (0.79-0.94), and cancer 0.90 (0.78-1.03) — the cancer interval crosses 1. The reduction in all-cause mortality was greatest at 2.0 cups a day, with no further reduction above it. That is tea generally, mostly green tea in the Asian cohorts and black tea in the European ones, at a standardised 150ml cup. It is an association, and it is not a finding about matcha.
Caffeine
Matcha’s caffeine tracks the powder rather than the cup: roughly 19-44mg per gram, so a standard 2g serving — about one level teaspoon — is about 38-89mg, most often around 60-70mg. A 3-4g koicha or strong latte is 57-178mg. See how much caffeine is in matcha for the measurement detail.
The FDA cites 400mg a day as an amount not generally associated with dangerous, negative effects in healthy adults, while explicitly noting wide variation in both sensitivity and metabolism. EFSA reaches the same 400mg figure for habitual daily intake and adds that single doses up to 200mg raise no safety concern. One serving is a modest share of that; two servings is roughly double the single-serving figure and still a minority of it.
These are population reference points rather than personal limits, and they cover the whole day’s intake — coffee, tea, energy drinks, cola and chocolate all count against the same total.
Signs of too much caffeine:
- Jitters or anxiety
- Trouble sleeping
- Increased heart rate
- Digestive issues
Catechins and EGCG
Matcha is rich in catechins, the group of compounds usually labelled antioxidants. The 2g daily dose in the 12-month trial was assayed at 170.8mg of total catechins including 105.3mg of EGCG; the 2.7g dose in the four-week trial at 301.5mg and 143mg. Both work out near 53mg of EGCG per gram of powder. A separate laboratory analysis of three commercial matcha products measured 15.3-16.9mg per gram, so per-gram measurements differ by roughly threefold between products — the same spread seen with caffeine. The figures here use the trial matchas.
The liver question
Very high doses of catechins have been associated with liver injury. EFSA reviewed this in 2018 and found that intake of 800mg or more of EGCG a day taken as a food supplement produced a statistically significant rise in serum transaminases in intervention trials. EFSA could not identify a safe dose for supplements, and concluded separately that catechins from traditionally prepared green tea infusions are generally safe.
The UK’s Committee on Toxicity re-examined the literature in 2024, judged the 800mg figure realistic, and found no evidence of hepatotoxicity below it in trials lasting up to 12 months. It also recorded hepatotoxicity for one specific product containing 375mg, and stated that it cannot be excluded that sensitive individuals could experience effects below 800mg through an idiosyncratic reaction. There is a mechanism behind that word: 72% of confirmed green tea extract liver injury cases carry the HLA-B*35:01 allele, which 5-15% of the population carries.
No authority has published an upper intake level for EGCG. The nearest derived figures come from a review of adverse-event data across 159 human intervention studies, which proposed an Observed Safe Level of 704mg a day for EGCG in beverage form and 338mg a day taken as a solid bolus. That review found hepatic events with concentrated preparations taken as large bolus doses, “but not when consumed as brewed tea or extracts in beverages or as part of food.”
At about 53mg of EGCG per gram, reaching the 704mg beverage level takes roughly 13g of powder a day, and the 800mg supplement signal roughly 15g — six to eight standard servings. Two servings a day is about 210mg, inside the 90-300mg a day EFSA estimates for mean adult intake from green tea infusions in the EU. Drinking matcha as a beverage is a different exposure from taking a concentrated extract, and that distinction is where the reassurance comes from. All of the liver data above is extract data; none of it is matcha data.
Lead
Tea leaves take up lead from soil and air. With steeped tea most of it stays in the leaf: Japan’s agriculture ministry measured about 8.8% of green tea’s lead transferring into the infusion, and a Chinese study of Tieguanyin brewing measured 10.2-70.4% depending on steep time and acidity. Matcha skips that filter, so per gram of leaf you take in roughly 3-10× the lead an infusion of the same leaf would give you. Full detail is in is there lead in matcha?.
A 2g serving of Japanese matcha carries roughly 0.13-0.6 µg of lead. Two benchmarks are usually quoted, and they answer different questions:
- The FDA’s Interim Reference Level for dietary lead is 8.8 µg/day, set for females of childbearing age and treated by FDA’s own review as the general-adult benchmark. A serving is 1-7% of it.
- California’s Proposition 65 Maximum Allowable Dose Level is 0.5 µg/day. A single serving straddles it.
Because this article is about a daily habit, the arithmetic compounds: one serving a day is 0.13-0.6 µg/day and two servings 0.26-1.2 µg/day, against a US adult dietary lead intake of 1.7-4.8 µg/day from food overall. Two servings a day sits at or above the Prop 65 level every day, and well below the FDA reference level. Quoting only one of those two numbers, in either direction, tells half the story.
There is no established safe level for lead — the WHO/FAO expert committee withdrew its provisional tolerable weekly intake in 2010 and could not set a health-protective replacement. Origin and testing are what move this number: Japanese green tea measures at the low end of every published dataset, and the 0.13-0.6 µg range above comes from Japanese matcha specifically.
What Scales With Each Serving
There is no published cutoff for servings a day, because no source assigns a safety verdict to a serving count. What can be stated is what each additional 2g serving adds, and the reference point each quantity is measured against:
| Quantity | One 2g serving | Published reference point |
|---|---|---|
| Caffeine | 38-89mg, usually around 60-70mg | FDA and EFSA: 400mg/day for healthy adults; EFSA: 200mg/day in pregnancy and while breastfeeding |
| EGCG | about 105mg | No upper intake level published; nearest derived level 704mg/day in beverage form |
| Lead | 0.13-0.6 µg | FDA Interim Reference Level 8.8 µg/day; Prop 65 level 0.5 µg/day |
All three scale roughly linearly with the powder. Beyond about two servings, the mortality evidence for tea offers no further reduction in risk, so more is not doing more on that measure either.
Who Should Talk to a Doctor First
Each of these has a specific reason behind it, and none of them can be resolved from a general figure.
- Pregnancy — EFSA and ACOG independently put caffeine at 200mg a day, and green tea reduced folic acid Cmax by 39.2% and AUC by 26.6% at a 0.4mg dose in healthy volunteers taking a folic acid supplement. Lead has no established safe level, and the 8.8 µg/day reference level is itself set for females of childbearing age. Talk to your doctor or midwife.
- Breastfeeding — EFSA reports that habitual intakes up to 200mg of caffeine a day by lactating women raise no safety concerns for breastfed infants; check with your doctor about your own intake.
- Children — EFSA’s level for ages 3-18 is 3mg per kg of body weight per day, which for a young child a single standard serving can meet or exceed on its own, and the FDA’s lead reference level for children is 2.2 µg/day. Ask a pediatrician.
- People taking medication — green tea reduced nadolol Cmax by 85.3% and AUC by 85.0% in healthy volunteers, and a 2025 review found 72% of clinical studies showed drug exposure reductions of 18-99%, across atorvastatin, digoxin, fexofenadine and rosuvastatin, mostly by inhibiting intestinal OATP1A2 uptake. Separately, and through caffeine rather than catechins, fluvoxamine inhibits CYP1A2 strongly enough that a single 20mg dose raised oral caffeine exposure fivefold and stretched caffeine’s half-life from about 5 hours to 31. Check with your pharmacist or prescriber about your specific drug.
- People taking warfarin or another vitamin K antagonist — matcha carries 2,900 µg of vitamin K per 100g, about 29 µg per gram or 58 µg in a 2g serving, where a sencha infusion carries only a trace, because vitamin K is fat-soluble and stays in the leaf. Vitamin K opposes warfarin; the clinical record is a 1999 case report of a patient drinking half a gallon to a gallon of green tea a day whose anticoagulation was lost and recovered to an INR of 2.55 on stopping. The practical issue is changing habitual intake rather than the vitamin K itself, so talk to your prescriber before starting, stopping or varying a daily matcha.
- People with iron deficiency — in a stable-isotope trial in 12 women, iron absorption from a meal was 5.7% with water, 3.6% with tea taken alongside the meal, and 5.7% with tea taken an hour afterwards. A one-hour gap is the measured remedy. Anyone being treated for deficiency should ask their doctor about timing relative to iron supplements.
- People with liver conditions — the hepatic signal above is a supplement and bolus-dose phenomenon, but the possibility of an idiosyncratic reaction below 800mg has not been excluded, and population-level reassurance is least informative for someone with existing liver disease. Talk to your doctor.
- Anyone sensitive to caffeine — adjust the amount of powder; the arithmetic is direct, and 1g lands at 19-44mg instead of 38-89mg.
Why People Drink It Daily
Commonly given reasons:
- An energy experience many people describe as calmer than coffee’s — attributed to L-theanine rather than to any difference in how the caffeine is absorbed
- Catechins
- L-theanine for focus and calm
- Ritual and mindfulness
These are reported reasons rather than demonstrated outcomes of a daily habit; the mortality evidence above belongs to tea generally, not to matcha.
The Bottom Line
What the numbers say. One to two 2g servings a day put the caffeine at a modest share of the 400mg a day FDA and EFSA both cite for healthy adults, the EGCG at roughly a seventh to a third of the nearest derived beverage Observed Safe Level, and the lead at a small fraction of ordinary dietary intake. Two servings a day for 12 months has the closest thing to direct evidence: a randomised trial in 99 older adults that reported no harmful events attributed to matcha.
What the numbers do not say. The whole direct human safety record for daily matcha is 145 participants and 12 months. No authority has set an upper intake level for EGCG, and the body that looked hardest said it could not. A daily 2g serving straddles the Prop 65 lead level, and two servings sit at or above it every day. Anything longer-term is extrapolated from studies of steeped tea.
If you have any of the specific circumstances above, or any other health concern, that conversation is with your own doctor or pharmacist rather than with a general figure.